Log in
Enquire now
‌

US Patent 12090075 Intragastric device

Patent 12090075 was granted and assigned to ReShape Lifesciences on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
ReShape Lifesciences
ReShape Lifesciences
0
Current Assignee
ReShape Lifesciences
ReShape Lifesciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120900750
Patent Inventor Names
Amy D. L. VandenBerg0
Antonio C. Llevares0
Andrew P. Rasdal0
Neil R. Drake0
Nelson Quintana0
Dubravka Markovic0
Mark C. Brister0
Kaushik A. Patel0
Date of Patent
September 17, 2024
0
Patent Application Number
175723870
Date Filed
January 10, 2022
0
Patent Citations
‌
US Patent 7674396 Method and system for treatment of eating disorders
0
‌
US Patent 7682306 Therapeutic intervention systems employing implantable balloon devices
0
‌
US Patent 7699863 Bioerodible self-deployable intragastric implants
0
‌
US Patent 7753949 Valve prosthesis systems and methods
0
‌
US Patent 7785291 Bioerodible self-deployable intragastric implants
0
‌
US Patent 7854745 Intragastric device
0
‌
US Patent 7879355 Method and system for treatment of eating disorders
0
‌
US Patent 7972378 Stents for prosthetic heart valves
0
...
Patent Primary Examiner
‌
Ryan J. Severson
0
CPC Code
‌
A61F 5/0083
0
‌
A61B 90/39
0
‌
A61B 17/12022
0
‌
A61B 17/12027
0
‌
A61B 17/12036
0
‌
A61B 17/1204
0
‌
A61B 17/12099
0
‌
A61L 31/088
0
...
Patent abstract

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12090075 Intragastric device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.